A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT) - Trial NCT06351605
Access comprehensive clinical trial information for NCT06351605 through Pure Global AI's free database. This phase not specified trial is sponsored by LumiThera, Inc. and is currently Recruiting. The study focuses on Dry Age-related Macular Degeneration. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
LumiThera, Inc.
Timeline & Enrollment
N/A
Sep 01, 2023
Dec 01, 2026
Primary Outcome
Best-Corrected Visual Acuity (BCVA)
Summary
The EUROLIGHT study is being conducted to collect real life data for the safety and
 effectiveness of PBM in dry AMD, in routine clinical practice both retrospectively and
 prospectively.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06351605
Device Trial